Delivery Order SPE2DB24D2013-SPE2DB25FCKAE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,785.75 to AmerisourceBergen Drug Corp for Jatenzo 237 mg capsules (120 count) on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $2,283.72 to AmerisourceBergen Drug Corp for Jatenzo 237 mg capsules (120-count supply) on September 9, 2025, with completion scheduled for September 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Jatenzo 237 mg capsules (120-count units) with a firm fixed price ceiling value of $1,483.15. This competitively awarded, non-set-aside delivery order is set for completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $1,131.88 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jatenzo 158 mg capsules (120-count unit). This firm fixed-price delivery order, which is a child contract under a larger vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. The award utilized no set-aside designation and was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Jatenzo 237 mg capsules (120-count units) with a ceiling value of $1,131.87. The contract is classified as a firm fixed price delivery order with an ultimate completion date of May 13, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $8,442.15 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Jatenzo 237 mg capsules (120-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 24, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $14,035.64 to AmerisourceBergen Drug Corp for the supply of Jatenzo 237 mg capsules (120-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 158 mg, valued at $1,142.26, with an ultimate completion date of September 22, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.39 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Jatenzo 237 mg capsules (120-count) with a ceiling value of $1,303.86. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCKAEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,405.27 to AmerisourceBergen Drug Corp for Jatenzo 237 mg capsules (120 count) on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills this order under its broader engagement with the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a diverse range of medications and medical commodities to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The award reflects the company's established capacity to meet federal procurement requirements for pharmaceutical products across multiple therapeutic domains through competitive, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/26/25 |